CYR 241
Alternative Names: CYR-241Latest Information Update: 05 Mar 2024
At a glance
- Originator Cyrus Biotechnology
- Class Bacterial proteins; Endopeptidases; Recombinant proteins
- Mechanism of Action Immunoglobulin G degraders
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Autoimmune disorders